| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| S-吡啶-2-基3-苯基丙硫醇酯 | 3-phenyl-S-(2'-pyridyl) thiopropionate | 43125-15-1 | C14H13NOS |
| S-叔丁基-L-半胱氨酸叔丁酯 | S-tert.-Butyl-L-cystein-tert.-butylester | 45157-84-4 | C11H23NO2S |
| S-乙酰基硫代胆碱 | acetylthiocholine | 4468-05-7 | C7H16NOS |
| S-乙基氨基甲酰-L-半胱氨酸 | Alanine, 3-ethylthiocarbamoyl-, L- | 4909-58-4 | C6H12N2O3S |
| S-丁基-D-半胱氨酸 | S-butyl-L-cysteine | 4134-56-9 | C7H15NO2S |
| S-[4-(2-甲基-2-丙基)苄基][2-(4-甲基环己基)-3-吡啶基]硫代氨基甲酸酯 | Carbonimidothioic acid, 3-pyridinyl-, S-((4-(1,1-dimethylethyl)phenyl)methyl)O-(4-methylcyclohexyl) ester | 42754-18-7 | C24H32N2OS |
| S-[4-(2-甲基-2-丙基)苄基][2-(3,5-二甲基环己基)-3-吡啶基]硫代氨基甲酸酯 | Carbonimidothioic acid, 3-pyridinyl-, O-(3,5-dimethylcyclohexyl) S-((4-(1,1-dimethylethyl)phenyl)methyl) ester | 42754-21-2 | C25H34N2OS |
| S-[4-(2-甲基-2-丙基)苄基][2-(3,4-二甲基环己基)-3-吡啶基]硫代氨基甲酸酯 | Carbonimidothioic acid, 3-pyridinyl-, O-(3,4-dimethylcyclohexyl) S-((4-(1,1-dimethylethyl)phenyl)methyl) ester | 42754-20-1 | C25H34N2OS |
| S-[4-(2-甲基-2-丙基)苄基][2-(2-甲基环己基)-3-吡啶基]硫代氨基甲酸酯 | Carbonimidothioic acid, 3-pyridinyl-, S-((4-(1,1-dimethylethyl)phenyl)methyl)O-(2-methylcyclohexyl) ester | 42754-17-6 | C24H32N2OS |
| S-[4-(2-甲基-2-丙基)苄基][2-(2,5-二甲基环己基)-3-吡啶基]硫代氨基甲酸酯 | Carbonimidothioic acid, 3-pyridinyl-, O-(2,5-dimethylcyclohexyl) S-((4-(1,1-dimethylethyl)phenyl)methyl) ester | 42754-19-8 | C25H34N2OS |
| S-Boc-2-巯基-4,6-二甲基嘧啶 | S-tert-butoxycarbonyl-4,6-dimethyl-2-mercaptopyrimidine | 41840-28-2 | C11H16N2O2S |
| S-2-羟基戊酸 | 2-(S)-hydroxyvaleric acid | 41014-93-1 | C5H10O3 |
| S-2-氯代戊二酸 | 2-chloro-pentanedioic acid | 4189-03-1 | C5H7ClO4 |
| S-1-CBZ-3-羟甲基哌啶 | N-Cbz-3-hydroxymethylpiperidine | 405061-52-1 | C14H19NO3 |
| S-(正丁基)-S-甲基二硫代碳酸酯 | S-Butyl S-methyl dithiocarbonate | 41320-26-7 | C6H12OS2 |
| S-(N,N-二甲基硫代氨甲酰基)巯基乙酸 | 2-{[(dimethylamino)carbothioyl]sulfanyl}ethanoic acid | 4007-01-6 | C5H9NO2S2 |
| S-(4-氯苄基)异硫脲 | S-(4-chlorobenzyl)isothiourea | 46124-27-0 | C8H9ClN2S |
| S-(3,4-二甲基苄基)-N-{[(2-甲基-2-丙基)氧基]羰基}-L-半胱氨酸 | N-Boc-S-<(3,4-dimethylphenyl)methyl>-L-cysteine | 41117-66-2 | C17H25NO4S |
| S-(2-羧乙基)-L-半胱氨酸 | S-(2-carboxyethyl)-L-cysteine | 4033-46-9 | C6H11NO4S |
| S-(2-羟基-5-硝基苄基)-6-硫代鸟苷 | S-(2-hydroxy-5-nitrobenzyl)-6-thioguanosine | 41094-07-9 | C17H18N6O7S |
| S-(2-噻唑基)-L-半胱氨酸 | S-(2-thiazolyl)-L-cysteine | 405150-20-1 | C6H8N2O2S2 |
| S-(2-噻吩基)-L-半胱氨酸 | S-(2-thienyl)-L-cysteine | 405150-23-4 | C7H9NO2S2 |
| S-(2-丙烯基)N-苯甲酰基硫代氨基甲酸酯 | S-(2-propenyl) N-benzoylmonothiocarbamate | 41876-77-1 | C11H11NO2S |
| S-((4-(1,1-二甲基乙基)苯基)甲基)2-(3-甲基环己基)-3-吡啶基硫代甲亚氨酸酯 | Carbonimidothioic acid, 3-pyridinyl-, S-((4-(1,1-dimethylethyl)phenyl)methyl O-(3-methylcyclohexyl) ester | 42723-79-5 | C24H32N2OS |
| S)-(-)-2-甲氧基丙酸乙酯 | ethyl (S)-2-methoxypropanoate | 41918-08-5 | C6H12O3 |
| S) FTY720磷酸酯 | (S)-fingolimod phosphate | 402616-26-6 | C19H34NO5P |
| S(+)-2-苯基丁酸 | (S)-2-phenylbutyric acid | 4286-15-1 | C10H12O2 |
| RAC 2-(4-苯甲醛基)丙酸 | 2-(4-formylphenyl)propanoic acid | 43153-07-7 | C10H10O3 |
| R-beta-甲基苯乙氨盐酸盐 | N-benzyl-1-phenylethan-1-aminium chloride | 49746-32-9 | C15H17N*ClH |
| R-N-苄基-5-氧代-3-吡咯烷甲酸甲酯 | methyl (R)-(-)-1-(phenylmethyl)-5-oxo-3-pyrrolidinecarboxylate | 428518-36-9 | C13H15NO3 |
| R-3-氨基-3-(1-萘基)丙酸盐酸盐 | (R)-3-Amino-3-(naphthalen-1-yl)propanoic acid hydrochloride | 499977-24-1 | C13H14ClNO2 |
| R)-1-苄基-3-N-叔丁氧羰基氨基哌啶 | tert-butyl (R)-(+)-(N-benzylpiperidin-3-yl)carbamate | 454713-13-4 | C17H26N2O2 |
| R(-)-去甲阿朴吗啡氢溴酸盐 | Norapomorphine | 478-76-2 | C16H15NO2 |
| Pseudotaraxasterol; (3beta,18alpha,19alpha)-乌苏-20-烯-3-醇 | pseudo-taraxasterol | 464-98-2 | C30H50O |
| ProteinC来源于人类血浆 | protein C (activated) | 42617-41-4 | —— |
| Pht-L-天冬酰胺 | <i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>-phthaloyl-L-asparagine | 42406-52-0 | C12H10N2O5 |
| Pexacerfont; 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-a]-1,3,5-三嗪-4-胺 | [14C]-Pexacerfont | 459856-18-9 | C18H24N6O |
| PYR41抑制剂 | Ethyl 4-[4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl]benzoate | 418805-02-4 | C17H13N3O7 |
| PSS-氯丙基-异丁基取代 | (3-chloropropyl)hepta(isobutyl)octasilsesquioxane | 480438-84-4 | C31H69ClO12Si8 |
| PSS-[2-(3,4-环氧环己基)乙基]-取代七异丁基 | 1,3,5,7,9,11,13-Heptakis(2-methylpropyl)-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane | 445379-56-6 | C36H76O13Si8 |
| PSS-(3-缩水甘油基)丙氧基-取代七异丁基 | Pss-(3-glycidyl)propoxy-heptaisobutyl S& | 444315-17-7 | C34H74O14Si8 |
| PSS-(3-巯基)丙基-七异丁基取代 | 1-(3-mercapto)propyl-3,5,7,9,11,13,15-isobutylpentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane | 480438-85-5 | C31H70O12SSi8 |
| PSS-(2-(反式-3,4-环己二醇)乙基)-七异丁基取代 | Pss-(2-(trans-3 4-cyclohexanediol)ethyl& | 480439-48-3 | C36H78O14Si8 |
| PIM-1抑制剂2 | 4-(3-(4-chlorophenyl)benzo[c]isoxazol-5-yl)pyrimidin-2-amine | 477845-12-8 | C17H11ClN4O |
| PHA-543613二盐酸盐 | PHA-543613 Dihydrochloride | 478148-58-2 | C15H19Cl2N3O2 |
| P-[[[1-[(6-氨基-9H-嘌呤-9-基)甲基]环丙基]氧基]甲基]-磷酸 | 1-((6-amino-9H-purin-9-yl)methyl)cyclopropoxymethylphosphoric acid | 441785-21-3 | C10H14N5O4P |
| P-[[[1-[(2-氨基-9H-嘌呤-9-基)甲基]环丙基]氧基]甲基]-磷酸 | Besifovir | 441785-25-7 | C10H14N5O4P |
| P,P-二苯基硫代膦酰肼 | diphenylphosphinothioic hydrazide | 41309-60-8 | C12H13N2PS |
| P,P-二环己基-N,N-二-2-吡啶基亚膦酰胺 | Py2NPCy2 | 472959-98-1 | C22H30N3P |
| P,P'-[(1,2-亚苯基)二(亚甲基)]二膦酸P,P,P',P'-四乙酯 | tetraethyl [1,2-phenylene-bis-(methylene)]bis(phosphonate) | 42092-05-7 | C16H28O6P2 |